- Home
- ESTA vs CDNA Comparison
ESTA vs CDNA Comparison
Compare ESTA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTA
- CDNA
- Stock Information
- Founded
- ESTA 2004
- CDNA 1998
- Country
- ESTA Costa Rica
- CDNA United States
- Employees
- ESTA N/A
- CDNA N/A
- Industry
- ESTA Industrial Specialties
- CDNA Medical Specialities
- Sector
- ESTA Health Care
- CDNA Health Care
- Exchange
- ESTA Nasdaq
- CDNA Nasdaq
- Market Cap
- ESTA 1.2B
- CDNA 1.1B
- IPO Year
- ESTA 2018
- CDNA 2014
- Fundamental
- Price
- ESTA $41.59
- CDNA $18.39
- Analyst Decision
- ESTA Buy
- CDNA Buy
- Analyst Count
- ESTA 6
- CDNA 8
- Target Price
- ESTA $59.17
- CDNA $29.43
- AVG Volume (30 Days)
- ESTA 433.2K
- CDNA 628.1K
- Earning Date
- ESTA 05-07-2025
- CDNA 05-08-2025
- Dividend Yield
- ESTA N/A
- CDNA N/A
- EPS Growth
- ESTA N/A
- CDNA N/A
- EPS
- ESTA N/A
- CDNA 0.93
- Revenue
- ESTA $166,025,000.00
- CDNA $333,785,000.00
- Revenue This Year
- ESTA $27.36
- CDNA $13.33
- Revenue Next Year
- ESTA $24.61
- CDNA $15.07
- P/E Ratio
- ESTA N/A
- CDNA $19.51
- Revenue Growth
- ESTA 0.53
- CDNA 19.07
- 52 Week Low
- ESTA $28.16
- CDNA $7.42
- 52 Week High
- ESTA $60.12
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- ESTA 57.01
- CDNA 42.77
- Support Level
- ESTA $38.47
- CDNA $16.98
- Resistance Level
- ESTA $41.66
- CDNA $20.00
- Average True Range (ATR)
- ESTA 2.23
- CDNA 0.82
- MACD
- ESTA 0.03
- CDNA 0.05
- Stochastic Oscillator
- ESTA 89.22
- CDNA 46.69
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.